Clinical Trials Logo

Clinical Trial Summary

Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR). The purpouse of this study is to evaluate the indication to a second TAVR, the selection criteria of the second transcatheter aortic valve, procedural and clinical outcomes. The primary endpoint of the study is overall mortality and Cardiovascular mortality at 1 year


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04500964
Study type Observational [Patient Registry]
Source IRCCS Policlinico S. Donato
Contact
Status Completed
Phase
Start date January 1, 2019
Completion date July 1, 2020